Protagonist Therapeutics, Inc.

8-K Director or officer change; Shareholder vote results Jun 18, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 10-K Fiscal year ended 2025-12-31 Feb 25, 2026 8-K Results of operations (earnings release) Feb 25, 2026 8-K Regulation FD disclosure Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Shareholder vote results Jun 26, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 8-K Other events Mar 20, 2025 8-K/A Other events Mar 11, 2025 8-K Other events Mar 10, 2025 8-K Other events Mar 3, 2025 10-K Fiscal year ended 2024-12-31 Feb 21, 2025 8-K Results of operations (earnings release) Feb 21, 2025 8-K Director or officer change Jan 6, 2025 8-K Entered a material agreement; Other events Nov 18, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Director or officer change Sep 20, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Amended charter or bylaws; Shareholder vote results Jun 26, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 10-K Fiscal year ended 2023-12-31 Feb 27, 2024 8-K Results of operations (earnings release) Feb 27, 2024 8-K Entered a material agreement Jan 31, 2024 8-K Other events Jan 16, 2024 8-K Regulation FD disclosure Jan 8, 2024 10-Q Quarter ended 2023-09-30 Nov 2, 2023 8-K Results of operations (earnings release) Nov 2, 2023 8-K Director or officer change Oct 30, 2023 10-Q Quarter ended 2023-06-30 Aug 3, 2023 8-K Results of operations (earnings release) Aug 3, 2023 8-K Other events Jul 5, 2023